0001209191-13-044107.txt : 20130912 0001209191-13-044107.hdr.sgml : 20130912 20130912200024 ACCESSION NUMBER: 0001209191-13-044107 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120511 FILED AS OF DATE: 20130912 DATE AS OF CHANGE: 20130912 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 11975 EL CAMINO REAL STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-792-6300 MAIL ADDRESS: STREET 1: 11975 EL CAMINO REAL STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rueckert William Dodge CENTRAL INDEX KEY: 0001380016 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50484 FILM NUMBER: 131095132 MAIL ADDRESS: STREET 1: 175 CASSIA WAY, SUITE 115 CITY: HENDERSON STATE: NV ZIP: 89014 4/A 1 c596599_4ax0.xml MAIN DOCUMENT DESCRIPTION X0306 4/A 2012-05-11 2012-05-15 0001262104 MEI Pharma, Inc. MEIP 0001380016 Rueckert William Dodge C/O MEI PHARMA, INC 11975 EL CAMINO REAL, SUITE 101 SAN DIEGO CA 92130 1 0 0 0 Common stock, par value $0.00000002 per share 2012-05-11 4 X 0 236 5.34 A 654 D Subscription rights (right to buy) 2.67 2012-05-11 4 X 0 2834 0 D 2012-03-30 2012-05-11 Units to purchase common stock and warrants 2834 0 D Warrants to purchase common stock, par value $0.00000002 7.14 2012-05-11 4 X 0 2834 7.14 A 2012-05-11 2017-05-10 Common stock 118 2834 D The number of securities and price reported previously have been adjusted for the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012. This form is being filed to correct the cumulative number of shares owned by the reporting person, which was incorrectly reported due an administrative error. The shares of common stock, par value $0.00000002 per share ("Common Stock") and warrants to purchase Common Stock were acquired in connection with the MEI Pharma, Inc. (the "Company") rights offering, the subscription period for which expired on May 11, 2012. In the rights offering, the Company distributed to its shareholders and holders of its Series A warrants, on a pro rata basis, subscription rights for the purchase of units. Each unit consisted of 0.0833 shares of the Company's Common Stock and warrants to purchase an additional 0.04167 shares of Common Stock at an exercise price of $7.14 per share. The subscription price for each unit was $2.67 (or $5.34 for two units representing one whole share of Common Stock). The reporting person exercised subscription rights for an aggregate of 2,834 units. Accordingly, upon the closing of the rights offering, the Company issued to the reporting person 236 shares of Common Stock and warrants to purchase an additional 118 shares. /s/ William D. Rueckert 2013-09-12